Does Anthem (Elevance Health) Cover Losartan?

What Is Losartan and Why Physicians Prescribe It

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for three distinct indications. It treats hypertension across a broad age range, reduces the risk of stroke in hypertensive patients with left ventricular hypertrophy, and slows the progression of diabetic nephropathy in patients with type 2 diabetes and proteinuria [1]. The standard oral dose range is 25 mg to 100 mg once daily, with 50 mg being the most common starting dose in adult hypertension [1].

ARBs block the AT1 receptor rather than inhibiting ACE, which means patients who develop ACE-inhibitor cough can often switch to losartan without that side effect [2]. Generic losartan has been available in the United States since 2010, making it one of the least expensive prescription antihypertensives on the market.

The LIFE trial (Losartan Intervention For Endpoint Reduction in Hypertension, N=9,193) published in The Lancet in 2002 demonstrated that losartan-based treatment reduced the composite of cardiovascular death, myocardial infarction, and stroke by 13% relative to atenolol-based treatment (P<0.001) in patients with hypertension and electrocardiographic left ventricular hypertrophy [3]. Losartan also produced a 25% relative risk reduction in stroke specifically (P<0.001) [3]. The 2023 American Heart Association / American College of Cardiology hypertension guideline lists ARBs as a first-line antihypertensive class alongside ACE inhibitors, thiazide-like diuretics, and dihydropyridine calcium channel blockers [4].

The American Diabetes Association's 2024 Standards of Care specifically recommend either an ACE inhibitor or an ARB as the preferred agent for patients with type 2 diabetes who have hypertension plus albuminuria, citing evidence of nephroprotection beyond blood pressure lowering alone [5]. Losartan 50 mg to 100 mg daily is one of the most commonly prescribed agents for this purpose.

How Anthem (Elevance Health) Formularies Are Structured

Anthem (Elevance Health) operates as a collection of regional Blue Cross Blue Shield licensee plans across more than 14 states, each with plan-specific formularies [6]. Generic losartan consistently appears on Anthem commercial formularies, but the tier assignment, copay amount, and any utilization management requirements vary by the specific product you purchased.

Anthem formularies typically use a 4- or 5-tier structure. Tier 1 contains preferred generics, Tier 2 contains non-preferred generics or preferred brands, Tier 3 contains non-preferred brands, and higher tiers contain specialty drugs. Generic losartan almost always lands at Tier 1 or Tier 2. Brand-name Cozaar, if it appears on the formulary at all, is placed at Tier 3 or higher, which substantially increases the patient's out-of-pocket obligation [6].

The Centers for Medicare and Medicaid Services (CMS) requires Medicare Part D plans to cover at least two ARBs in the renin-angiotensin system (RAS) blocker category [7]. Anthem's Part D plans accordingly cover generic losartan, usually without prior authorization. Medicaid managed care plans administered by Anthem may follow state-specific preferred drug lists that place losartan as preferred or non-preferred depending on the state [7].

The only way to know your exact tier and copay is to run your plan's specific formulary lookup tool at anthem.com, search the drug name "losartan," and enter your plan ID. Your Summary of Benefits and Coverage (SBC) document also lists cost-sharing tiers and any utilization management flags [6].

Prior Authorization Criteria for Losartan on Anthem

Prior authorization (PA) for generic losartan on Anthem commercial plans is uncommon but not rare. It appears most often in two scenarios: a prescriber requests brand-name Cozaar instead of the generic, or the plan has imposed PA on all ARBs as a cost-control measure in certain employer-sponsored benefit designs [8].

When PA is required, Anthem's standard clinical criteria for losartan typically include the following. The prescribing clinician must document an FDA-approved diagnosis (hypertension, left ventricular hypertrophy with hypertension, or diabetic nephropathy in type 2 diabetes). For brand Cozaar specifically, Anthem generally requires that the patient has tried and failed, or is clinically contraindicated to, the generic equivalent [8].

The 2022 ACCP/ASHP/APhA consensus statement on prior authorization reform states that PA requirements "should be evidence-based, clearly communicated, and resolved within 72 hours for non-urgent cases and within 24 hours for urgent cases" [9]. Anthem's internal PA turnaround target for standard non-urgent requests is 3 business days, and urgent requests are processed within 24 hours as required by state law in most jurisdictions.

To submit a PA for losartan, the prescriber's office typically completes Anthem's online form through Availity or submits a fax to the plan's pharmacy prior authorization department with the following documentation: office notes showing diagnosis and blood pressure measurements, recent labs (BMP or CMP for renal function if diabetic nephropathy is the indication), and a letter of medical necessity if brand is being requested [8].

HealthRX PA Submission Checklist for Losartan on Anthem:

1. Confirm the ICD-10 code matches an FDA-approved indication (I10 for hypertension, I50.x for heart failure context, N18.x or E11.65 for diabetic nephropathy).
2. Pull a 90-day medication history showing prior ACE inhibitor trial if step therapy applies.
3. Document the reason for brand if requesting Cozaar (e.g., inactive ingredient allergy confirmed by allergist).
4. Attach most recent serum creatinine, eGFR, and urine albumin-to-creatinine ratio for nephropathy indication.
5. Submit through Availity; note the case reference number.
6. Follow up at 48 hours if no response.

Step Therapy Requirements Before Losartan on Anthem

Some Anthem employer-sponsored plans require step therapy before approving an ARB, meaning the patient must first try an ACE inhibitor (lisinopril, ramipril, or enalapril are common first-step agents) [10]. The rationale is cost: generic ACE inhibitors often cost $4 per month at large pharmacy chains, and clinical outcomes data show broadly similar blood pressure lowering between the two classes for most hypertensive patients without an ACE-intolerant or ARB-specific indication [4].

Step therapy for losartan is most commonly waived when the prescriber documents: a history of ACE-inhibitor-associated angioedema, persistent dry cough on ACE inhibitor therapy, pregnancy (both classes are contraindicated, but this is relevant if switching from an ACE inhibitor started before pregnancy was known), hyperkalemia on ACE inhibitor, or a diagnosed condition where ARBs specifically have guideline-supported superiority (such as Marfan syndrome or IgA nephropathy) [10].

The ONTARGET trial (N=25,620) published in the New England Journal of Medicine in 2008 showed that telmisartan was non-inferior to ramipril for the composite of cardiovascular death, MI, stroke, and heart failure hospitalization (RR 1.01 to 95% CI 0.94 to 1.09) [11]. Anthem's clinical reviewers are aware of this equivalence data, which is why step therapy favoring ACE inhibitors before ARBs is considered clinically defensible by most payers.

If your plan imposes step therapy and you believe it is clinically inappropriate, the prescriber can submit a step therapy exception request with supporting documentation. Eleven states have enacted step therapy reform laws requiring plans to grant exceptions within specific timeframes when clinical criteria are met [10].

What Anthem Pays and What You Pay: Cost Math

Generic losartan's list price runs approximately $80 per month for brand Cozaar, while the generic costs roughly $10 per month at cash-pay pricing through GoodRx-type discount programs [12]. With Anthem Tier 1 coverage and a standard commercial plan copay structure, most patients pay $0 to $15 for a 30-day supply.

A 90-day supply through Anthem's mail-order pharmacy (IngenioRx, Anthem's pharmacy benefits manager) often reduces that cost further. Many Anthem plans charge $0 to $30 for a 90-day supply of Tier 1 generics through mail order, making the annualized cost of losartan therapy negligible compared to the cost of uncontrolled hypertension complications [12].

The FDA approved generic losartan potassium tablets in 25 mg, 50 mg, and 100 mg strengths from multiple manufacturers [1]. Therapeutic substitution within the ARB class (for example, valsartan or irbesartan) is generally not required by Anthem because losartan itself is already generic and inexpensive.

High-deductible health plans (HDHPs) are the main exception. Before the deductible is met, you pay the plan's negotiated rate rather than a flat copay. The negotiated rate for generic losartan on most Anthem HDHPs is typically $10 to $25 per 30-day fill, still well below the brand list price [12].

The National Heart, Lung, and Blood Institute (NHLBI) estimates that untreated or poorly controlled hypertension costs the U.S. health care system approximately $131 billion per year in direct medical costs [13]. From a payer perspective, covering a $10 generic antihypertensive to prevent a $50,000 stroke hospitalization is straightforward actuarial math, which is why most Anthem plans cover losartan without friction.

How to Appeal an Anthem Denial of Losartan

Anthem denies losartan claims for a small subset of patients, most often because step therapy documentation is incomplete, the brand was requested without medical necessity justification, or the plan's formulary simply does not list the drug [14]. Each of these reasons has a distinct appeal path.

Step 1: Internal Appeal. Federal law under the Affordable Care Act (ACA) gives you 180 days from the denial date to file an internal appeal [14]. The appeal should include a written letter from the prescriber explaining the clinical rationale, any step therapy documentation, and supporting literature. Anthem is required to respond to internal appeals within 30 days for prospective denials and within 60 days for retrospective denials.

Step 2: External Review. If Anthem upholds the denial after internal appeal, you have the right to request an Independent Review Organization (IRO) review. The IRO is a third-party organization certified by the state insurance commissioner. For most Anthem commercial plans, the IRO decision is binding on Anthem [14]. IRO requests must be filed within 4 months of the internal appeal decision in most states.

Step 3: State Insurance Commissioner Complaint. Filing a complaint with the state insurance commissioner in parallel with an IRO request is not prohibited and sometimes accelerates resolution. Anthem's compliance team typically responds faster when a regulatory body is copied [14].

The U.S. Department of Labor's Employee Benefits Security Administration (EBSA) publishes the ACA appeal rights summary and the ERISA external review requirements applicable to self-funded Anthem plans at dol.gov. For state-regulated fully-insured plans, the relevant authority is the state insurance department [14].

For a denial based specifically on step therapy, the prescriber's letter should cite the patient's documented intolerance (cough, angioedema, hyperkalemia) and reference the AHA/ACC 2023 guideline recommendation that ARBs are first-line alternatives to ACE inhibitors in patients who cannot tolerate ACE inhibitors [4].

The American College of Cardiology notes that physicians should document ACE-inhibitor intolerance "contemporaneously in the medical record at the time of the adverse event, not retrospectively at the time of the prior authorization request" [4]. Retrospective documentation does not carry the same weight with Anthem's clinical reviewers.

Losartan Dose Titration and Monitoring While Navigating Insurance

Insurance approvals are dose-specific on some Anthem plans. A PA approved for losartan 50 mg does not automatically authorize losartan 100 mg on plans that use quantity limits [1]. Prescribers should confirm the approved dose matches the prescribed quantity before the patient fills the prescription.

The standard titration schedule per the FDA label is to start at 50 mg once daily in most hypertensive adults, with the option to increase to 100 mg once daily if blood pressure response is inadequate after 3 to 6 weeks [1]. In patients with intravascular volume depletion (for example, patients on diuretics), starting at 25 mg once daily reduces the risk of symptomatic hypotension [1].

Monitoring parameters while on losartan include serum potassium, serum creatinine, and blood pressure at each follow-up. The 2023 AHA/ACC guideline recommends reassessing blood pressure control and lab values 1 month after initiating or changing antihypertensive therapy [4]. For patients with diabetic nephropathy, the ADA 2024 Standards of Care recommend checking urine albumin-to-creatinine ratio and eGFR at least annually [5].

A serum potassium above 5.5 mEq/L while on losartan warrants dose reduction or discontinuation. Losartan is absolutely contraindicated in pregnancy (FDA category D in the second and third trimesters based on fetal renal toxicity data) [1]. Women of childbearing age should use effective contraception and be counseled about this risk at every prescription renewal.

Manufacturer Savings Cards and Patient Assistance for Losartan

Because losartan is available as an inexpensive generic, a manufacturer savings card for brand Cozaar is rarely relevant. Merck, the original manufacturer, does not actively promote Cozaar savings programs for commercially insured patients [12]. Generic copay cards from third-party programs are also largely unnecessary given that most Anthem Tier 1 copays are already $0 to $15.

Federal anti-kickback statutes prohibit using manufacturer copay assistance cards when Medicare or Medicaid is the primary payer [15]. This applies regardless of the Anthem product. A patient with Anthem Medicare Advantage cannot legally use a manufacturer coupon for Cozaar at the pharmacy. Violation can constitute a federal false claims act offense for the prescriber if they direct patients to these programs while knowingly billing Medicare [15].

For patients who are uninsured or underinsured, the NeedyMeds database (needymeds.org) lists patient assistance programs for losartan from several generic manufacturers, though eligibility criteria vary by income [12]. The cost of generic losartan at $10 per month cash pay is low enough that most patients do not need additional assistance.

Losartan vs. Other ARBs on the Anthem Formulary

Anthem formularies typically list multiple ARBs. The most commonly covered agents alongside losartan include valsartan, irbesartan, olmesartan, and candesartan, all of which are now generic [6]. Formulary position varies. On some Anthem plans, valsartan or irbesartan may be preferred over losartan at Tier 1, while losartan sits at Tier 2, or vice versa.

The 2023 AHA/ACC guideline does not rank ARBs against each other for general hypertension, treating them as clinically interchangeable for blood pressure lowering [4]. The JNC 8 panel's 2014 report in JAMA similarly stated that thiazides, CCBs, ACE inhibitors, and ARBs are all acceptable first-line agents with comparable outcomes data in most populations [16].

Where losartan has specific trial-level evidence that other ARBs lack: the LIFE trial (N=9,193) for stroke risk reduction in patients with electrocardiographic LVH [3], and the RENAAL trial (N=1,513) published in the New England Journal of Medicine in 2001, which showed losartan 50 to 100 mg daily reduced the risk of the composite of doubling of serum creatinine, end-stage renal disease, or death by 16% vs. placebo in patients with type 2 diabetic nephropathy (P<0.02) [17]. These trial data support losartan specifically when Anthem's PA reviewers question substituting a different ARB.

The RENAAL trial also showed that losartan reduced the risk of ESRD alone by 28% vs. placebo (P<0.002) and reduced first hospitalization for heart failure by 32% (P<0.005) [17]. These numbers are useful reference points when drafting a letter of medical necessity.

Managing Quantity Limits and Refill Timing on Anthem

Anthem pharmacy plans impose dispensing limits aligned with the FDA label. For losartan, this is typically a 30-day supply per fill at retail pharmacy or a 90-day supply per fill at mail order [6]. Quantity limits per fill generally match the labeled maximum daily dose: 100 mg per day for hypertension and 100 mg per day for nephropathy.

Early refill rules on most Anthem plans allow a refill when 75% of the prior supply has been used (the "75% rule"). For a 30-day supply, this means the next fill is available at day 22 or 23. Pharmacists can override the early refill lock for documented vacation supplies (typically up to a 90-day supply at retail) if the plan allows vacation overrides.

Switching from retail to mail order mid-therapy requires a new prescription sent directly to IngenioRx or Anthem's designated mail-order pharmacy. The prescriber submits the prescription electronically specifying a 90-day supply. The first mail-order fill is typically shipped within 7 to 10 business days.